Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Long Term Debt 2010-2025 | MKKGY

Merck long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • Merck long term debt for the quarter ending March 31, 2025 was $7.337B, a 13.62% decline year-over-year.
  • Merck long term debt for 2024 was $7.571B, a 24.28% decline from 2023.
  • Merck long term debt for 2023 was $9.999B, a 3.16% increase from 2022.
  • Merck long term debt for 2022 was $9.693B, a 0.93% decline from 2021.
  
Merck Annual Long Term Debt
(Millions of US $)
2024 $7,571
2023 $9,999
2022 $9,693
2021 $9,784
2020 $11,177
2019 $9,681
2018 $7,890
2017 $9,080
2016 $9,748
2015 $10,671
2014 $4,734
2013 $4,327
2012 $4,324
2011 $0
2010 $0
2009 $0
Merck Quarterly Long Term Debt
(Millions of US $)
2025-03-31 $7,337
2024-12-31 $7,571
2024-09-30 $8,669
2024-06-30 $8,424
2024-03-31 $8,493
2023-12-31 $9,999
2023-09-30 $10,383
2023-06-30 $10,353
2023-03-31 $9,831
2022-12-31 $9,693
2022-09-30 $9,333
2022-06-30 $9,988
2022-03-31 $9,299
2021-12-31 $9,784
2021-09-30 $9,664
2021-06-30 $10,508
2021-03-31 $10,852
2020-12-31 $11,177
2020-09-30 $69
2020-06-30 $11,100
2020-03-31 $11,183
2019-12-31 $9,681
2019-09-30 $9,579
2019-06-30 $7,303
2019-03-31 $5,732
2018-12-31 $7,890
2018-09-30 $8,249
2018-06-30 $9,648
2018-03-31 $9,755
2017-12-31 $9,080
2017-09-30 $9,481
2017-06-30 $8,966
2017-03-31 $8,911
2016-12-31 $9,748
2016-09-30 $9,581
2016-06-30 $10,494
2016-03-31 $10,217
2015-12-31 $10,671
2015-09-30 $10,190
2015-06-30 $7,609
2015-03-31 $8,159
2014-12-31 $4,734
2014-09-30 $2,868
2014-06-30 $2,657
2014-03-31 $2,628
2013-12-31 $4,327
2013-09-30 $4,338
2013-06-30 $4,314
2013-03-31 $4,445
2012-12-31 $4,324
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.608B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.504B 29.07
Zoetis (ZTS) United States $65.610B 24.48
Daiichi Sankyo, - (DSNKY) Japan $46.052B 23.60
Takeda Pharmaceutical (TAK) Japan $45.947B 9.14
BeOne Medicines - (ONC) Cayman Islands $31.996B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.212B 0.00
Summit Therapeutics (SMMT) United States $19.562B 0.00
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $13.222B 11.70
Neurocrine Biosciences (NBIX) United States $13.047B 44.69
Orion OYJ (ORINY) Finland $10.973B 26.45
IPSEN (IPSEY) France $10.477B 0.00
Corcept Therapeutics (CORT) United States $7.436B 60.45
Madrigal Pharmaceuticals (MDGL) United States $7.348B 0.00
Stevanato Group S.p.A (STVN) Italy $7.320B 44.76
Grifols, S.A (GRFS) Spain $6.876B 0.00
Ionis Pharmaceuticals (IONS) United States $6.613B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.383B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.202B 0.00
Hypermarcas (HYPMY) Brazil $3.004B 19.76
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.563B 8.98
NewAmsterdam Pharma (NAMS) Netherlands $2.533B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.479B 13.41
Centessa Pharmaceuticals (CNTA) United Kingdom $2.145B 0.00
Ocular Therapeutix (OCUL) United States $1.834B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.783B 0.00
ARS Pharmaceuticals (SPRY) United States $1.753B 0.00
Endo (NDOI) United States $1.656B 0.00
Harrow (HROW) United States $1.360B 0.00
Guardian Pharmacy Services (GRDN) United States $1.322B 0.00
Evotec AG (EVO) Germany $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 23.30
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.062B 0.00
Ardelyx (ARDX) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.042B 0.00
Akebia Therapeutics (AKBA) United States $1.009B 0.00
Collegium Pharmaceutical (COLL) United States $0.993B 5.36
Verve Therapeutics (VERV) United States $0.974B 0.00
ProKidney (PROK) United States $0.942B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.804B 0.00
KalVista Pharmaceuticals (KALV) United States $0.777B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.732B 0.00
Xencor (XNCR) United States $0.648B 0.00
Zevra Therapeutics (ZVRA) United States $0.641B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
Organogenesis (ORGO) United States $0.578B 0.00
Elite Pharmaceuticals (ELTP) United States $0.569B 0.00
Theravance Biopharma (TBPH) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.564B 12.26
Bioventus (BVS) United States $0.518B 13.12
Oruka Therapeutics (ORKA) United States $0.516B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.468B 0.00
Aquestive Therapeutics (AQST) United States $0.420B 0.00
Savara (SVRA) United States $0.396B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 9.46
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Altimmune (ALT) United States $0.328B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.308B 0.00
AleAnna (ANNA) United States $0.300B 0.00
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.08
OmniAb (OABI) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.241B 0.00
Esperion Therapeutics (ESPR) United States $0.228B 0.00
MediWound (MDWD) Israel $0.217B 0.00
Larimar Therapeutics (LRMR) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.196B 0.00
China SXT Pharmaceuticals (SXTC) China $0.188B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Liminatus Pharma (LIMN) United States $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.111B 18.25
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.105B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Wellgistics Health (WGRX) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.066B 0.00
Inotiv (NOTV) United States $0.059B 0.00
Jupiter Neurosciences (JUNS) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Klotho Neurosciences (KLTO) United States $0.055B 0.00
ElectroCore (ECOR) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.89
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Incannex Healthcare (IXHL) Australia $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.37
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00